This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,304.87, is a firm fixed-price delivery order for the supply of 4565331970 - Methylergonovine 0.2 mg/ml vial. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.44 firm fixed-price contract is for the delivery of 4557734719 methylergonovine 0.2 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,794.96 contract is for the delivery of the drug methylergonovine 0.2 mg/ml to support military treatment programs and facilities. The contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to...
This $1,270.65 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566477281 METHYLERGONOVINE 0.2 MG/ML VLML, with a completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.20, is for the delivery of 4568112775 methylergonovine 0.2 mg tablets. The contract has a period of performance through May 5, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide METHYLERGONOVINE 0.2 MG/ML VLML, a specialty pharmaceutical product, with a potential value of $5,126.30. The delivery order has a completion date of February 12, 2024 and does not fall under any set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC)...
This federal contract award, valued at $1,794.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order contract for the supply of 4565019375 - Methylergonovine 0.2 mg/ml VLML, a pharmaceutical product, with a completion date of June 28, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylergonovine 0.2 mg tablets, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price of $1,208.02 and a period of performance through April 11, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug...
This federal contract award, valued at $2,991.60, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of METHYLERGONOVINE 0.2 MG/ML VLML, with a performance period ending on June 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565213357 Methyldopa 250 mg tablets in 90-count packages. The contract has a firm fixed price of $1,128.47 and a period of performance through July 22, 2024. It is not a set-aside contract. As a large pharmaceutical vendor, Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal...